Security Snapshot

KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) Institutional Ownership

CUSIP: 31572Q881

13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

31

Shares (Excl. Options)

1,034,728

Price

$6.78

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-116,562
Value change
-$1,066,549
Number of holders
31
Issuer context 3 identity fields
Shares outstanding
4,044,489
SEC-reported price per share
$7.37
Insider filing price
$7.37
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value is tracked under CUSIP 31572Q881.
  • 31 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 32 to 31 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $10,102,543 to $7,013,757.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 31 institutions filings for Q1 2026.

Open SEC Evidence

Security key

31572Q881

Latest holder period

Q1 2026

13F holders

31

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
KYNB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.9% +6% $3,508,000 +$192,940 400,000 +5.8% Armistice Capital, LLC 31 Dec 2025
VANGUARD GROUP INC 4.4% $916,888 178,040 The Vanguard Group 30 Jun 2025

As of 31 Mar 2026, 31 institutional investors reported holding 1,034,728 shares of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB). This represents 26% of the company’s total 4,044,489 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
26%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 9.9% 400,000 0% 0.09% $2,712,000
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 156,607 0% 0% $1,061,795
ACADIAN ASSET MANAGEMENT LLC 2.6% 105,585 0% 0% $714,000
BlackRock, Inc. 2.1% 84,331 -0.42% 0% $571,765
TWO SIGMA INVESTMENTS, LP 1.2% 49,511 -19% 0% $335,685
GEODE CAPITAL MANAGEMENT, LLC 1.1% 45,998 +5.2% 0% $311,935
HighTower Advisors, LLC 0.98% 39,744 -0.01% 0% $269,464
UBS Group AG 0.68% 27,591 +193% 0% $187,067
RENAISSANCE TECHNOLOGIES LLC 0.68% 27,481 -13% 0% $186,321
VANGUARD FIDUCIARY TRUST CO 0.59% 23,942 0% 0% $162,327
Birchview Capital, LP 0.56% 22,566 0.09% $152,997
STATE STREET CORP 0.5% 20,284 0% 0% $137,526
JANE STREET GROUP, LLC 0.3% 12,228 -2.2% 0% $82,906
ADAR1 Capital Management, LLC 0.26% 10,469 0% 0% $70,980
GROUP ONE TRADING LLC 0.11% 4,492 -2.1% 0% $30,456
Vanguard Global Advisers, LLC 0.04% 1,424 0% 0% $9,655
Axiom Investment Management LLC 0.02% 704 0% 0% $4,773
MORGAN STANLEY 0.01% 488 -92% 0% $3,308
Tower Research Capital LLC (TRC) 0.01% 332 +54% 0% $2,251
HARBOUR INVESTMENTS, INC. 0% 200 0% $1,356
NATIONAL BANK OF CANADA /FI/ 0% 193 0% $1,305
OSAIC HOLDINGS, INC. 0% 180 +76% 0% $1,220
SBI Securities Co., Ltd. 0% 152 0% 0% $1,031
ROYAL BANK OF CANADA 0% 132 0% 0% $1,000
BNP PARIBAS FINANCIAL MARKETS 0% 50 0% 0% $339

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,034,728 $7,013,757 -$1,066,549 $6.78 31
2025 Q4 1,150,872 $10,102,543 -$49,623 $8.78 32
2025 Q3 1,132,318 $13,869,418 +$1,072,340 $12.25 30
2025 Q2 1,045,108 $5,537,068 +$5,536,814 $5.30 27
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .